NeoGenomics Inc (NEO)

Add to Watchlists
Create an Alert
Quickflows
50.97 +0.11  +0.22% NASDAQ Feb 26, 20:00 USD
View Full Chart
Price Chart
View All Key Stats

Key Stats

View All NEO News

News

View All Events

Events

Date Type Description
04/28/2021 Earnings NeoGenomics Inc First Quarter Earnings Results for 2021
04/28/2021 Misc NeoGenomics Inc First Quarter Earnings Conference Call for 2021
02/24/2021 Earnings NeoGenomics Inc Fourth Quarter Earnings Result for 2020
02/24/2021 08:30 EST Misc NeoGenomics Inc Fourth Quarter Earnings Conference Call for 2020
10/27/2020 Earnings NeoGenomics Inc Third Quarter Earnings Result for 2020
10/27/2020 08:30 EDT Misc NeoGenomics Inc Third Quarter Earnings Conference Call for 2020
07/28/2020 08:30 EDT Misc NeoGenomics Inc Second Quarter Earnings Conference Call for 2020
07/28/2020 Earnings NeoGenomics Inc Second Quarter Earnings Result for 2020
05/28/2020 10:00 EDT Misc NeoGenomics Inc Annual General Meeting for 2019
04/28/2020 08:30 EDT Misc NeoGenomics Inc First Quarter Earnings Conference Call for 2020
View All Performance Charts

Total Returns Comparison

Fundamentals

Income Statement View Statement

Revenue (TTM) 444.45M
Total Expenses (TTM) 458.44M
Net Income (TTM) 4.172M

Balance Sheet View Statement

Total Assets (Quarterly) 988.33M
Total Liabilities (Quarterly) 294.04M
Shareholders Equity (Quarterly) 694.29M

Cash Flow Statement View Statement

Cash from Operations (TTM) 1.46M
Cash from Investing (TTM) -159.44M
Cash from Financing (TTM) 235.60M

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.neogenomics.com
  • Investor Relations URL: http://ir.neogenomics.com/
  • HQ State/Province: Florida
  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Apr. 28, 2021
  • Last Earnings Release: Feb. 24, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Pharma Services. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. The company generates revenue from Clinical Services.

Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 50.97
Price Target Upgrade
Price Target Upside (Daily) Upgrade

Top Fund Holders

Symbol Name Weighting
PSCH Invesco S&P SmallCap Health Care ETF 4.88%
EDOC Global X Telemedicine & Digital Hlth ETF 4.26%
ARTSX Artisan Small Cap Investor 3.89%
BASAX Brown Advisory Small-Cap Growth Adv 2.45%
HSCCX Carillon Eagle Small Cap Growth C 1.66%
FSSRX Franklin Small Cap Growth R 1.39%
DIGGX Invesco Discovery R5 1.23%
IJT iShares S&P Small-Cap 600 Growth ETF 1.21%
SLYG SPDR® S&P 600 Small Cap Growth ETF 1.21%
VTSIX Vanguard Tax-Managed Small Cap I 0.64%
IJR iShares Core S&P Small-Cap ETF 0.59%
SPSM SPDR® Portfolio S&P 600 Sm Cap ETF 0.59%

Comparables

Edit
VCEL Vericel Corp
CYTK Cytokinetics Inc
INSM Insmed Inc
IONS Ionis Pharmaceuticals Inc
UTHR United Therapeutics Corp

Other Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.